Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul 27:12:676141.
doi: 10.3389/fimmu.2021.676141. eCollection 2021.

IL2RA Methylation and Gene Expression in Relation to the Multiple Sclerosis-Associated Gene Variant rs2104286 and Soluble IL-2Rα in CD8+ T Cells

Affiliations

IL2RA Methylation and Gene Expression in Relation to the Multiple Sclerosis-Associated Gene Variant rs2104286 and Soluble IL-2Rα in CD8+ T Cells

Sophie Buhelt et al. Front Immunol. .

Abstract

CD8+ T cells are involved in the pathogenesis of multiple sclerosis (MS). The interleukin-2 receptor α (IL-2Rα) is important for CD8+ T cell function, and single nucleotide polymorphisms (SNPs) in the IL2RA gene encoding IL-2Rα increase the risk of MS. Therefore, in isolated CD8+ T cells we investigated IL2RA gene methylation and gene expression in relation to the MS-associated IL2RA SNP rs2104286 and soluble IL-2Rα (sIL-2Rα). We have identified allele specific methylation of the CpG-site located in intron 1 that is perturbed by the rs2104286 SNP in CD8+ T cells from genotype-selected healthy subjects (HS). However, methylation of selected CpG-sites in the promotor or 5'UTR region of the IL2RA gene was neither associated with the rs2104286 SNP nor significantly correlated with IL2RA gene expression in HS. In CD8+ T cells from HS, we explored expression of immune relevant genes but observed only few associations with the rs2104286 SNP. However, we found that sIL-2Rα correlated negatively with expression of 55 immune relevant genes, including the IL-7 receptor gene, with Spearman's rho between -0.49 and -0.32. Additionally, in HS by use of flow cytometry we observed that the IL-7 receptor on naïve CD8+ T cells correlated negatively with sIL-2Rα and was downregulated in carriers of the rs2104286 MS-associated risk genotype. Collectively, our study of resting CD8+ T cells indicates that the rs2104286 SNP has a minor effect and sIL-2Rα may negatively regulate the CD8+ T cell response.

Keywords: CD8+ T cells; IL-7 receptor alpha; IL2RA; allele specific methylation; interleukin-2 receptor alpha; multiple sclerosis; rs2104286; sCD25.

PubMed Disclaimer

Conflict of interest statement

SB has received support for congress participation from Biogen and Merck. H-ML currently works at AGC Biologics but had no conflicts of interest at the time of performing the study described in this paper. AO has served on scientific advisory boards for Biogen Idec, Novartis, and Sanofi Genzyme; has received research support from Novartis and Biogen Idec; has received speaker honoraria from Biogen Idec, Novartis and TEVA; and has received support for congress participation from Merck, TEVA, Biogen, Roche, Novartis, and Sanofi Genzyme. FS has served on scientific advisory boards for, served as consultant for, received support for congress participation or received speaker honoraria from Alexion, Biogen, Merck, Novartis, Roche, and Sanofi Genzyme. His laboratory has received research support from Biogen, Merck, Novartis, Roche, and Sanofi Genzyme. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
(A) Overview of the 6 CpG-sites in the IL2RA regulatory region and intron 1 that passed quality control and were methylated above background. Four CpG-sites were in the region corresponding to the 5’UTR and 1 CpG-site was located upstream of this in the promotor region. CpG10:6057082 was located in intron 1 at the site of rs2104286. (B) Methylation at the CpG10:6057082 that is perturbed by the MS-associated IL2RA rs2104286 SNP in healthy subjects (CC = 20; CT = 5; TT = 25) and MS patients (CC = 1; CT = 7; TT = 4). Of the 50 HS, 38 were from cohort 1 and 12 were from cohort 2. Data were analysed by one-way analysis of variance. Error-bars represent mean with SD.
Figure 2
Figure 2
Surface expression of the IL-7Rα on CD8+ T cells in relation to sIL-2Rα and the MS-associated SNP rs2104286. (A) Spearman correlation between sIL-2Rα and frequency (freq.) of IL-7Rα+CD8+ T cells in healthy subjects (N = 33). (B) The freq. of IL-7Rα+ cells on naïve, CM, EM and TEMRA subsets. (C) Spearman correlation between sIL-2Rα and the freq. of IL-7Rα+ naïve (CD45RAhiCCR7+) CD8+ T cells, freq. of IL-7Rα+ central memory (CM, CD45RA-CCR7+) CD8+ T cells, freq. of IL-7Rα+ effector memory (EM, CD45RA-CCR7-) CD8+ T cells as well as freq. of IL-7Rα+ terminal effector memory (TEMRA, CD45RAhiCCR7-) CD8+ T cells in healthy subjects (N = 31). Gating strategy is presented in Supplementary Figure 2. (D) The MS-associated SNP rs2104286 in relation to the freq. of IL-7Rα+CD8+ T cells (TT = 18, CC = 14) and the freq. of IL-7Rα+ naïve CD8+ T cells (TT = 18, CC = 13) in genotype-selected healthy subjects. Genotype comparisons were analysed by a non-parametric Mann-Whitney U test. Error-bars represent median with interquartile range. ns, non-significant.

Similar articles

Cited by

References

    1. Baecher-Allan C, Kaskow BJ, Weiner HL. Multiple Sclerosis: Mechanisms and Immunotherapy. Neuron (2018) 97:742–68. 10.1016/j.neuron.2018.01.021 - DOI - PubMed
    1. Salou M, Nicol B, Garcia A, Laplaud D-A. Involvement of CD8+ T Cells in Multiple Sclerosis. Front Immunol (2015) 6:604. 10.3389/fimmu.2015.00604 - DOI - PMC - PubMed
    1. Lassmann H. Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis. Front Immunol (2019) 9:3116. 10.3389/fimmu.2018.03116 - DOI - PMC - PubMed
    1. Ratzer R, Søndergaard HB, Christensen JR, Börnsen L, Borup R, Sørensen PS, et al. . Gene Expression Analysis of Relapsing-Remitting, Primary Progressive and Secondary Progressive Multiple Sclerosis. Mult Scler (2013) 19:1841–8. 10.1177/1352458513500553 - DOI - PubMed
    1. Hauser SL, Bhan AK, Gilles F, Kemp M, Kerr C, Weiner HL. Immunohistochemical Analysis of the Cellular Infiltrate in Multiple Sclerosis Lesions. Ann Neurol (1986) 19:578–87. 10.1002/ana.410190610 - DOI - PubMed

Publication types

Substances